The risk calculator shows improved precision in a population larger than the original dataset used to validate the tool.

Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an ...

The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

Melanoma is one of the most aggressive forms of skin cancer, arising from pigment-producing cells called melanocytes. While ...

Doctors discuss the prevalence, risks and treatments of metastatic melanoma, as Teddi Mellencamp reveals the latest updates ...

Summer can mean a rise in visible freckles. But how do you know when a freckle is harmless versus whether it might actually be concerning?

New spots and lesions appearing on your skin, especially after sun exposure, can be alarming. While often harmless age spots, ...

Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started ...

Intermountain Health is unveiling an exciting new treatment program for Utahns with advanced melanoma cancer, ...

Tumor-infiltrating lymphocyte therapy is now available at two hospitals in Utah, offering a cutting-edge treatment for ...